Massive study aims to perfect testicular cancer survivor monitoring
NCT ID NCT02229916
First seen Jan 14, 2026 · Last updated May 21, 2026 · Updated 25 times
Summary
This study follows 6,900 men who have completed treatment for testicular cancer. Researchers want to find the best way to detect if the cancer returns and to track long-term side effects like heart problems or second cancers. The goal is to create smarter follow-up schedules that catch relapses early while reducing unnecessary scans and radiation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TESTICULAR NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kantonsspital St.Gallen; Onkologie/Haematologie
RECRUITINGSankt Gallen, 9007, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.